A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19. Published in The Lancet Microbe ...
In a recent study published in The Lancet Microbe, researchers investigated the effects of molnupiravir on the evolution of ...